Tools.acc.org
ASCVD Risk Estimator
WebFor Optimal Use: Estimate patient’s 10-year ASCVD risk at an initial visit to establish a reference point. Forecast the potential impact of different interventions on patient risk. Reassess ASCVD risk at follow-up visits. Follow up risk incorporates change in risk factor levels over time and requires both initial and follow up values.
Actived: Just Now
URL: https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/
ASCVD Risk Estimator
WebNote: These estimates may underestimate the 10-year and lifetime risk for persons from some race/ethnic groups, especially American Indians, some Asian Americans (e.g., of south Asian ancestry), and some Hispanics (e.g., Puerto Ricans), and may overestimate the risk for others, including some Asian Americans (e.g., of east Asian ancestry) and some …
Statin Intolerance
WebWalk through the steps of treating and managing a patient who reports muscle symptoms, including cycles of statin discontinuation and rechallenge to identify a tolerated statin and dose. 1. Evaluate Evaluate possible intolerance to patient's current statin prescription. 2. Follow-Up Follow steps to treat and manage possible statin-related
ASCVD Risk Estimator
WebAbout the Application. This Risk Estimator is intended as a companion tool to the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.This Risk Estimator enables health care providers and patients to …
About ACC Calculator Home
WebAbout ACC Calculator Home. The ACC and the American Heart Association (AHA), in collaboration with the National Heart, Lung, and Blood Institute and other specialty societies, have released four guidelines focused on the assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk and management of elevated blood …
LDL-C Lowering Therapy
WebConsiderations for Lowering LDL-C. Consider ezetimibe and/or PCSK9 mAb. Please refer to the 2018 Guideline information on ezetimibe and the 2018 Guideline information on PCSK9 mAb.; If lipid-lowering response is still less-than-anticipated , it may be reasonable to consider bempedoic acid or inclisiran.
AnticoagEvaluator
WebRenal Function. SCr mg/dL. CrCl mL/min. This app applies only to patients who HAVE atrial fibrillation and DO NOT HAVE moderate to severe mitral stenosis and/or a mechanical heart valve. See full Guideline Recommendations in the Resources section for those patients with a mechanical valve. This app is not yet updated with the 2023 Guideline for
DAPT Risk Calculator
WebDAPT Risk Calculator. The DAPT Score was created in patients who had completed 12 months of DAPT without having a major bleeding or ischemic event and who were not on chronic oral anticoagulation. The DAPT Risk Calculator is recommended to be used for guidance in the overall conversation about dual antiplatelet therapy and not as a
TAVR In-Hospital Mortality Risk Calculator
WebDerived using eGFR (MDRD equation) and presence or absence of regular dialysis. (30 to 90 mL/min/1.73m2) Creatinine level closest to the date and time prior to the procedure and anesthetic management. The presence or absence of regular dialysis is required to determine the calculated GFR value.
Top Categories
Popular Searched
› Healthy drive thru restaurant
› Healthy eating at school pdf
› Connect for adventist health
› Health and weight loss retreats
› Health product packaging design
› Banda health company directors
› Consumer health question 6 pdf
Recently Searched
› Azure services health dashboard
› Inpatient treatment mental health
› What is optimal health definition
› Health & safety report template
› Mental health facilities mistreatment
› Dept of public health massachusetts
› Physical health articles for teens
› Greystone home health care daytona